Pharmacogenomic Research in Korean Patients With Hepatitis C

Inje University

Status: Completed

Conditions: Chronic Hepatitis C

Study type: Observational

Funder types: Other

Identifiers

NCT01453244

11-037

Details and patient eligibility

About

The aim of this study is to investigate the relationships between drug response and the host genetic factors, viral factors and clinical factors in chronic hepatitis C patients (HCV). And thus, the investigators are trying to develop the pharmacogenomic guideline in the Korean patients with HCV.

Enrollment: 373 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hepatitis C virus infected patients

Exclusion criteria

• Patients who infected Hepatitis B virus or Human immunodeficiency virus
• HCV infected patients previously treated with antiviral drugs
• Patients had a history of autoimmune hemolytic anemia

Trial design

373 participants in 2 patient groups

SVR group

Description:

A patients who achieved SVR (sustained virologic response)

non-SVR group

Description:

A patients who not achieved SVR (sustained virologic response)